When it comes to AI, there are three types: artificial narrow intelligence (ANI), artificial general intelligence (AGI), and artificial superintelligence. Artificial narrow intelligence has a narrow range of abilities as it can only perform one task at any time, therefore it is dubbed as weak AI. Then comes artificial general intelligence (AGI) which has the same level of human capabilities to perform tasks, and lastly artificial superintelligence which is software that can exceed human intelligence in every aspect. Artificial superintelligence (ASI) is a type of artificial intelligence with much greater intellectual capabilities than humans.
In the next decade, machines and applications intelligence will be superior to humans in any field–we could use these machines to find a cure for cancer, develop a new vaccine in just a few days, or be used by criminals and terrorists alike to execute smart attacks like the next fire sale cyber-attack.
For instance, as Dr. Noga Yerushalmi, investment director at M Ventures and member of the investment committee of AION labs stated, “The use of AI to try and solve challenges in biomedical research is not new but has become increasingly the focus of new research and novel technologies with the accumulation of more data in this field.”